Astex Pharmaceuticals to Announce 2011 Fourth Quarter and Year-End Financial Results on March 5, 2012
DUBLIN, Calif.--(BUSINESS WIRE)--
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company
dedicated to the discovery and development of novel small molecule
therapeutics, today announced that it will release its 2011 fourth
quarter and fiscal year-end results on Monday, March 5, 2012. James S.J.
Manuso, PhD, chairman and chief executive officer, and the Astex
Pharmaceuticals management team will provide details of the Company's
financial results and provide guidance for fiscal year 2012.
A press release will be issued following the close of the market on
March 5th. The Company will host a webcast conference call to discuss
the results at 4:30 p.m. ET. A live webcast of the call will be
available in the Investor Events section of the Company's website at www.astx.com.
A webcast replay of the conference call will be available shortly
following the event. Alternatively, you may access a replay of the
conference call by dialing (855) 859-2056 (domestic) and (404) 537-3406
(international); the replay passcode number is 51684061. The webcast
replay will be available for 30 days, and the telephone replay will be
available for 7 days.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of
novel small molecule therapeutics with a focus on oncology. The Company
is developing a proprietary pipeline of novel therapies and is creating
de-risked products for partnership with leading pharmaceutical
companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for
Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
Astex Pharmaceuticals, Inc.
Timothy L. Enns, 925-560-2810
Senior
Vice President
Corporate Communications & Marketing
tim.enns@astx.com
Susanna
Chau, 925-560-2845
Manager
Investor Relations
susanna.chau@astx.com
or
The
Trout Group
Alan Roemer, 646-378-2945
Managing Director
aroemer@troutgroup.com
or
College
Hill
Melanie Toyne-Sewell (Europe), +44 20 7866 7866
Rebecca
Skye Dietrich (US), 857-241-0795
astex@collegehill.com
Source: Astex Pharmaceuticals, Inc.
News Provided by Acquire Media
Close window | Back to top
Delicious
Digg
Facebook
LinkedIn
Twitter
Mixx
Yahoo! Buzz